Literature DB >> 7436559

Venous syndromes and pulmonary embolism in systemic lupus erythematosus.

D D Gladman, M B Urowitz.   

Abstract

Deep vein thrombophlebitis (DVT) and pulmonary emboli (PE) have been uncommonly reported manifestations of systemic lupus erythematosus (SLE). This may be partly due to their being masked by other more familiar lesions of the lungs and extremities in SLE. We have identified 17 patients with SLE from a population of 180 being followed up prospectively who had 21 attacks of DVT and/or PE. Of the total of 21 episodes the SLE was considered to be active in 14, inactive in 6, and variable in a patient with recurring phlebitis. The incidence of hyperlipidaemia, smoking history, and use of birth control medication or corticosteroids was not higher in these patients. These clinical findings thus constitute additional features of SLE occurring in about 9% of patients and may be significance for morbidity and mortality.

Entities:  

Mesh:

Year:  1980        PMID: 7436559      PMCID: PMC1000553          DOI: 10.1136/ard.39.4.340

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  8 in total

1.  THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS DESPITE CIRCULATING ANTICOAGULANTS.

Authors:  E J BOWIE; J H THOMPSON; C A PASCUZZI; C A OWEN
Journal:  J Lab Clin Med       Date:  1963-09

2.  PERIPHERAL VASCULAR SYNDROMES ASSOCIATED WITH SYSTEMIC LUPUS ERYTHEMATOSUS.

Authors:  D ALARCON SEGOVIA; P J OSMUNDSON
Journal:  Ann Intern Med       Date:  1965-05       Impact factor: 25.391

3.  The natural history of systemic lupus erythematosus: an approach to its study through chronic biologic false positive reactors.

Authors:  J E MOORE; W B LUTZ
Journal:  J Chronic Dis       Date:  1955-03

4.  Clinical diagnosis of systemic lupus erythematosus.

Authors:  R ARMAS-CRUZ; J HARNECKER; G DUCACH; J JALIL; F GONZALEZ
Journal:  Am J Med       Date:  1958-09       Impact factor: 4.965

5.  Thrombosis of renal veins and inferior vena cava complicating lupus nephritis.

Authors:  C R Hamilton; P A Tumulty
Journal:  JAMA       Date:  1968-12-02       Impact factor: 56.272

6.  Renal vein thrombosis, nephrotic syndrome, and focal lupus glomerulonephritis.

Authors:  V Gutierrez Millet; G Usera; J M Alcazar de la Ossa; L M Ruilope; M T Ortuno; J L Rodicio
Journal:  Br Med J       Date:  1978-01-07

7.  Renal vein thrombosis, nephrotic syndrome, and systemic lupus erythematosus: an association in four cases.

Authors:  G B Appel; G S Williams; J I Meltzer; C L Pirani
Journal:  Ann Intern Med       Date:  1976-09       Impact factor: 25.391

8.  Thrombophlebitis in systemic lupus erythematosus.

Authors:  B Peck; G S Hoffman; W A Franck
Journal:  JAMA       Date:  1978-10-13       Impact factor: 56.272

  8 in total
  13 in total

1.  Circulating lupus type anticoagulant and pulmonary hypertension associated with mixed connective tissue disease.

Authors:  P Hainaut; E Lavenne; J M Magy; E G Lebacq
Journal:  Clin Rheumatol       Date:  1986-01       Impact factor: 2.980

2.  Arterial occlusion causing large bowel infarction--a reflection of clotting diathesis in SLE.

Authors:  R A Asherson; S H Morgan; E N Harris; A E Gharavi; T Krausz; G R Hughes
Journal:  Clin Rheumatol       Date:  1986-01       Impact factor: 2.980

3.  Venous thrombosis in SLE.

Authors:  T Gibson
Journal:  Ann Rheum Dis       Date:  1981-02       Impact factor: 19.103

4.  Pulmonary hypertension in systemic lupus erythematosus.

Authors:  A Oktay; A Oto
Journal:  Br Med J (Clin Res Ed)       Date:  1983-11-26

5.  Acquired antithrombin III deficiency and systemic lupus erythematosus.

Authors:  M P Jarrett; A I Grayzel; P Barland; I Sussman
Journal:  Ann Rheum Dis       Date:  1981-04       Impact factor: 19.103

6.  Intestinal perforation. A common complication of scleroderma.

Authors:  E C Ebert; F M Ruggiero; J R Seibold
Journal:  Dig Dis Sci       Date:  1997-03       Impact factor: 3.199

7.  Relation between antithrombin III and clinical and serological parameters in systemic lupus erythematosus.

Authors:  M P Jarrett; D Green; C H Ts'ao
Journal:  J Clin Pathol       Date:  1983-03       Impact factor: 3.411

8.  Antiphospholipid syndrome: five year follow up.

Authors:  R A Asherson; E Baguley; C Pal; G R Hughes
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

9.  Splenic and renal infarction in systemic lupus erythematosus: association with anti-cardiolipin antibodies.

Authors:  M H Arnold; L Schrieber
Journal:  Clin Rheumatol       Date:  1988-09       Impact factor: 2.980

10.  Splenic infarction associated with anticardiolipin antibodies in a patient with acquired immunodeficiency syndrome.

Authors:  M S Cappell; T Simon; M Tiku
Journal:  Dig Dis Sci       Date:  1993-06       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.